Seminars in Respiratory and Critical Care Medicine

Papers
(The median citation count of Seminars in Respiratory and Critical Care Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Long-Term Antibiotics in Bronchiectasis63
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension58
Improving Medication Adherence in Asthma44
Sleep, Circadian Rhythms, and Lung Cancer42
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens42
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis40
Mechanical Ventilation for COVID-19 Patients35
Primary Ciliary Dyskinesia32
Nonmalignant Pleural Effusions32
Severe Infections Due to Respiratory Viruses30
28
Impact of Marijuana Use on Lung Health27
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease21
Lung Transplant for Chronic Obstructive Pulmonary Disease18
Prevention of Aspiration: Oral Care, Antibiotics, Others17
Pseudomonas aeruginosa in Bronchiectasis17
Antibiotic Strategies for Severe Community-Acquired Pneumonia14
Indwelling Pleural Catheter: Management of Complications14
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection14
Imaging in the Intensive Care Unit14
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative14
COVID-19-Related Pleural Diseases13
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management13
13
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis12
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease12
Deployment-Related Respiratory Disease: Where Are We?12
Any Role of High-Dose Vitamin C for Septic Shock in 2021?11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease11
Pulmonary Physiology and Medicine of Diving11
Definition and Epidemiology of Sepsis11
11
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen11
Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia10
Update on Sepsis Epidemiology in the Era of COVID-1910
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues10
Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement and Association with Outcomes10
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome10
Understanding the Updates in the Asthma Guidelines10
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases10
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease9
Work-Related Sleep Disorders: Causes and Impacts9
Bronchoscopic Lung Volume Reduction: A Review9
How to Survive Sepsis: Patient Testimonial9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care8
Malignant Central Airway Obstruction: What's New?8
Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis8
Evidence for the Application of Sepsis Bundles in 20218
Diagnosis and Management of Invasive Candida Infections in Critically Ill Patients8
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-198
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP7
Interstitial Lung Disease Associated with Systemic Sclerosis7
Intra-abdominal Infections7
Aspergillus and the Lung7
Management of Acutely Decompensated Pulmonary Hypertension7
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice7
Defining Clinical and Microbiological Nonresponse in Ventilator-Associated Pneumonia6
6
Arterial Blood Gases and Acid–Base Regulation6
“Long Haulers”6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests6
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management6
Pulmonary Hypertension Associated with Left Heart Disease6
Sleep and Circadian-Related Outcomes after Critical Illness6
Life-Threatening Infections: Pulmonary and Systemic Infections6
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis6
Invasive Pulmonary Aspergillosis in Hospital and Ventilator-Associated Pneumonias6
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure6
Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy6
Aspiration Pneumonia: Preface6
Severe Community-Acquired Pneumonia6
Pathological Diagnosis of Pulmonary Aspergillosis6
Bronchiectasis Exacerbations: Definitions, Causes, and Acute Management6
The Deteriorating Patient: Therapies Including Lung Transplantation6
Severe Community-Acquired Pneumonia in Immunocompromised Patients6
Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia6
Use of Antiviral Agents and other Therapies for COVID-196
Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants5
Phenotyping, Precision Medicine, and Asthma5
COVID-19 in Immunocompromised Patients: A Systematic Review5
HIV and COVID-19 Disease5
Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement5
Gas Exchange in the Lung5
Approach to Pulmonary Nodules in Connective Tissue Disease5
Mediastinal Staging with Endobronchial Ultrasound in Early-Stage Non—Small Cell Lung Cancer: Is It Necessary?5
The Role of Viral Infections in the Development and Progression of COPD5
Control of Breathing5
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?5
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease5
Vaccination against Respiratory Infections in the Immunosenescent Older Adult Population: Challenges and Opportunities5
The Spectrum of Pulmonary Aspergillosis5
Imaging in Asthma Management5
Advances in Disease-Modifying Therapeutics for Chronic Neuromuscular Disorders5
Global Trends in Occupational Lung Disease5
Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia4
4
HAP and VAP after Guidelines4
Pulmonary Vascular Disease in Chronic Obstructive Pulmonary Disease4
Diagnosis and Initial Investigation of Bronchiectasis4
What Is the Role of Steroids for Septic Shock in 2021?4
Malignant Pleural Effusions in the Era of Immunotherapy and Antiangiogenic Therapy4
Pleural Diseases in Connective Tissue Diseases4
Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care4
Importance of and Approach to Taking a History of Exposures to Occupational Respiratory Hazards4
Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension4
Life After COVID-19: Alterations Related to Sleep and Circadian Rhythms4
Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT4
Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae4
Risk of Multidrug-Resistant Pathogens in Severe Community-Acquired Pneumonia4
Bacteriology of Aspiration Pneumonia: The Lung Microbiome and the Changing Microbial Etiology4
Swallowing and Aspiration: How to Evaluate and Treat Swallowing Disorders Associated with Aspiration Pneumonia in Older Persons3
Transmission and Risk Factors of COVID-19 among Health Care Workers3
3
COVID-19 Vaccines—All You Want to Know3
Dysregulation of Host–Pathogen Interactions in Sepsis: Host-Related Factors3
High-Resolution Computed Tomography of Cystic Lung Disease3
Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment3
3
Environmental Interventions for Asthma3
Techniques for Oxygenation and Ventilation in Coronavirus Disease 20193
Cystic Fibrosis3
Aspiration Pneumonia3
Modeling Mechanical Ventilation In Silico—Potential and Pitfalls3
Expert Review on Spontaneous Pneumothorax: Advances, Controversies, and New Directions3
Aspiration after Critical Illness: Role of Endotracheal Tube, Tracheostomy, and Swallowing Disorders3
Management of Severe Influenza3
3
3
Nutrition in Asthma3
Systemic Lupus Erythematosus-related Lung Disease3
Early Experience on Universal Prophylaxis in Infants against Respiratory Syncytial Virus: Facts and Expectations3
Optimizing Fluid Resuscitation and Preventing Fluid Overload in Patients with Septic Shock3
3
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update3
Corrigendum: Severe Community-Acquired Pneumonia: Noninvasive Mechanical Ventilation, Intubation, and HFNT3
Ventilation Mechanics3
Medical Emergencies in Pulmonary Hypertension3
Evaluation of Neuromuscular Disease in Adults Presenting with Dyspnea3
Five Questions to Help Prompt End-of-Life Planning in Neuromuscular Disease2
Bronchiectasis: Advances in Diagnosis and Treatment2
Management of Chronic Neuromuscular Respiratory Failure in the Intensive Care Unit2
New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia2
Aspiration after Anesthesia: Chemical versus Bacterial, Differential Diagnosis, Management, and Prevention2
Imaging of Lung Disease Associated with Connective Tissue Disease2
Middle East Respiratory Syndrome Coronavirus2
Integrated Multiorgan Bedside Ultrasound for the Diagnosis and Management of Sepsis and Septic Shock2
Viral Respiratory Infections: From Bench to Bedside2
Review of Pulmonary Physiology2
Management of Pulmonary Arterial Hypertension2
Antimicrobial Strategies for Cystic Fibrosis2
Glucocorticoid Therapy in COVID-192
Artificial Intelligence in Quantitative Chest Imaging Analysis for Occupational Lung Disease2
Epigenetic Mechanisms in Sepsis-Associated Acute Kidney Injury2
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators2
Pulmonary Aspergillosis in People with Cystic Fibrosis2
New Insights in the Pathophysiology of Hospital- and Ventilator-Acquired Pneumonia: A Complex Interplay between Dysbiosis and Critical-Illness–Related Immunosuppression2
Nonmalignant Central Airway Obstruction: Options for Challenging Cases2
Sepsis from Science to Social Perspective2
0.042431116104126